Watching this approximately 10 minute webcast is a good way of
rapidly understanding endobarrier and its potential
effectiveness in type 2 diabetes. It was this presentation
which inspired the current ABCD sponsored,
multi-centre, endobarrier study (REVISE-Diabesity). The
study has recently been published:
de Jonge C,et al. Obes
Surg. 2013 Sep;23(9):1354-60